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Abstract 
Patients with laryngeal cancer have a high risk of developing lung cancer in the future. A 
patient presented with a complaint of left-sided chest pain for the last 3 months. Chest 
X-ray posterior-anterior view showed a homogeneous opacity in the left upper lung field 
with elevation of the diaphragm on the left side. CECT thorax revealed a 
heterogeneously enhancing soft tissue density mass lesion in the superior segment of 
the lingular lobe. On histopathological examination of the mass lesion, it was diagnosed 
as adenocarcinoma of the lung. About 10 months previously, the patient was treated for 
a laryngeal squamous cell carcinoma. Patients with laryngeal cancer should be routinely 
screened during follow-up with chest X-ray or CT scan for the early detection of lung 
cancer. 
Introduction 
Patients with head and neck cancers including laryngeal cancer have a high risk for 
developing second primary lung cancers because of the common etiological agent of 
smoking. Supraglottic laryngeal cancer is more commonly associated with second 
primary lung cancer as compared to glottic cancer. The development of second primary 
lung cancer adversely affects the survival rate of patients with head and neck cancer 
including laryngeal cancer. So, patients with head and neck cancer should be routinely 
screened during follow-up with chest X-ray or CT scan for the early detection of lung 
cancer.  
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Case Report 
A 62-year-old male patient presented with a complaint of left-sided chest pain for the last 3 months. 
There was no history of fever, cough, shortness of breath or hemoptysis. On examination, vitals were 
normal. There was no lymphadenopathy, pallor or clubbing. On respiratory system examination, air 
entry was decreased in the left infraclavicular, suprascapular and interscapular area on auscultation. 
There was no abnormal finding on examination of the cardiovascular system, gastrointestinal system or 
CNS system. 
On laboratory investigation, CBC, blood sugar, renal function test and liver function test were within 
normal limits. 
Chest X-ray posterior-anterior view (fig. 1) showed homogeneous opacity in the left upper lung field 
with elevation of the diaphragm on the left side. CECT thorax (fig. 2) was suggestive of a 
heterogeneously enhancing soft tissue density mass lesion in the superior segment of the lingular lobe 
with obliterated lingular lobe bronchus and consolidation and collapse of the anterior segment of the 
left upper lobe and lingular lobe. On histopathological examination of the mass lesion, it was diagnosed 
as a case of adenocarcinoma of the lung (fig. 3). 
About 10 months before, the patient presented at the ENT department of our hospital with a 
complaint of hoarseness for the last 2 months; he was diagnosed as a case of glottic laryngeal cancer and 
was treated by radiotherapy to which the patient responded well. An ultrasonography of the neck done 
at that time showed a hyperechoic nodule in the right vocal cord (fig. 4), which on biopsy was 
diagnosed as well-differentiated squamous cell carcinoma (fig. 5). 
The patient was diagnosed as a case of second primary lung adenocarcinoma with glottic laryngeal 
squamous cell carcinoma as index tumor. He was referred to the radiotherapy department for further 
management. 
Written informed consent was obtained from the patient for publication of this case report and any 
accompanying images. 
Discussion 
Head and neck cancers constitute about 6% of all cancers [1]. Tobacco and alcohol are 
the major etiological agents associated with the development of head and neck cancer. 
Because of common etiological factors, patients with head and neck cancer are at risk for 
developing second primary malignancies at a rate of 4–7% per year [2]. Slaughter et al. [3] 
proposed the theory of ‘field cancerization’, according to which continuous exposure to 
common etiological agents leads to the development of second primary cancer. According 
to Wu et al. [4], carcinogenic agents such as tobacco and alcohol cause irreversible genetic 
and histologic changes which lead to the development of second primary cancer. The 
development of second primary cancers in patients with head and neck cancer partly 
affects the overall survival rate of the index tumor [5]. 
The lung is the most common site for the development of a second primary tumor 
after head and neck cancer [6]. Most second primary lung cancers occur synchronously 
within 24 months to index head and neck cancer [7]. Oro-hypopharynx or larynx are the 
most common sites of index head and neck tumor and ‘squamous cell’ is the most 
common histological type of index head and neck tumor associated with second primary 
lung cancer development [8]. Supraglottic laryngeal cancer is more commonly associated 
with second primary lung cancer as compared to glottic cancer [9, 10]. The prognosis for 
second primary lung cancer in association with a head and neck carcinoma is poor 
because it is diagnosed in advanced stage [11] and this in turn affects the overall survival 
of patients with head and neck cancer. 
Early detection of a second primary lung cancer is important for prolonging the 
survival of patients with head and neck cancer. All head and neck cancer patients should  
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be routinely screened using chest X-rays for early detection of a second primary lung 
cancer [12]. But screening by chest X-rays has failed to improve survival in patients with 
secondary lung cancer [12]. Screening for lung cancer by CT scan has a higher detection 
rate as compared to chest X-rays [13, 14]. Chest CT or PET-CT scan should be used for 
early detection of second primary lung cancer, especially if the site of head and neck 
carcinoma are the oro-hypopharynx or larynx, if the cell type is squamous cell carcinoma, 
and if initial chest X-ray findings are abnormal [8]. 
 
 
 
 
 
Fig. 1. Chest X-ray posterior-anterior view showing homogeneous opacity in the left upper lung field 
with an elevation of the diaphragm on the left side. 
 
 
 
Fig. 2. CECT thorax showed a heterogeneously enhancing soft tissue density mass lesion in the 
superior segment of the lingular lobe with an obliterated lingular lobe bronchus with consolidation and 
collapse of the anterior segment of the left upper lobe and lingular lobe. 
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Fig. 3. Histopathological examination of the mass lesion of the lung suggestive of adenocarcinoma of 
the lung. 
 
 
 
Fig. 4. Ultrasonography of the neck showing a hyperechoic nodule in the right vocal cord. 
 
 
 
Fig. 5. Biopsy from the nodular lesion of the right vocal cord showing well-differentiated squamous 
cell carcinoma. 
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